Additional Information

Description

Morphine 10 mg/mL in 1 mL vials is a potent opioid analgesic used for the management of moderate to severe pain. It acts by binding to opioid receptors in the central nervous system (CNS), modulating pain perception and response. The product is intended for single-dose administration and is commonly employed in acute care settings, including surgical, trauma, and palliative care scenarios.

This injectable solution is typically administered via intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes. Morphine has a rapid onset of action, with analgesic effects beginning within 5–10 minutes when given IV, and lasting 3–5 hours depending on the route of administration. Dosage and administration must be tailored to the individual’s pain level, clinical condition, and opioid tolerance.

Adverse effects associated with morphine use include respiratory depression, sedation, nausea, vomiting, and hypotension. Careful monitoring is essential, especially in opioid-naïve patients or those with impaired hepatic, renal, or respiratory function. Morphine is contraindicated in patients with severe respiratory depression, acute asthma, or gastrointestinal obstruction.